• Home
  • About
  • Best Selling Diet Books
  • Diet and Weight Loss Videos
  • Contact Us

Diet & Weight Loss

Tips and Advice

  • Featured
  • Healthy Weight Loss Tips
  • Lifestyle Changes for Weight Loss
  • Healthy Weight Loss Foods
  • Weight Loss News

Ozempic and Wegovy may boost health, from addiction to dementia – BBC.com

By Weight Loss

  1. Ozempic and Wegovy may boost health, from addiction to dementia  BBC.com
  2. Sweeping review suggests weight-loss drugs’ effect on 175 conditions  The Washington Post
  3. Weight-loss jabs linked to reduced risk of 42 conditions including dementia  The Guardian
  4. Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds  CNN
  5. Weight-loss drugs reduce risk of Alzheimer’s, large study shows  Financial Times
  6. Ozempic: Weight-Loss Drug’s Benefits And Risks Revealed in New Study  ScienceAlert
  7. Obesity drugs: huge study highlights new health risks  Nature.com
  8. Study identifies benefits, risks linked to popular weight-loss drugs  WashU Medicine
  9. Scientists unveil benefits and risks of blockbuster weight-loss drugs  Euronews

Brought to you by Google News. Read the rest of the article here

  • Facebook
  • Twitter

Filed Under: Weight Loss News

https://www.youtube.com/watch?v=uTTsXW6hzk0
  • Email
  • Facebook
  • Pinterest
  • Twitter

Recent Posts

  • Why Some People Are Microdosing Popular Weight-Loss Drugs – WSJ May 25, 2025
  • Can weight loss drugs help you drink less alcohol? – Live Science May 24, 2025
  • Cigna to offer $200 Wegovy, Zepbound weight-loss benefit – Reuters May 23, 2025
  • Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs – CNBC May 22, 2025
  • Cheryl Burke Reveals 35-Lb. Weight Loss, Says It Wasn’t for the ‘Aesthetic’ (Exclusive) – People.com May 21, 2025
  • Weight-loss medications may also benefit common medical problem, study finds – Fox News May 20, 2025

Copyright © 2025 · Designed by Amaraq Websites · Privacy Policy · Affiliate Disclosure